Needham & Company LLC Reaffirms “Hold” Rating for Zimmer Biomet (NYSE:ZBH)

Zimmer Biomet (NYSE:ZBH – Get Free Report)‘s stock had its “hold” rating reiterated by equities research analysts at Needham & Company LLC in a research note issued on Tuesday, Benzinga reports. A number of other research analysts have also weighed in on the company. UBS Group reduced their target price on Zimmer Biomet from $112.00 […]

Leave a Reply

Your email address will not be published.

Previous post Vulcan Forged PYR (PYR) Self Reported Market Capitalization Achieves $70.36 Million
Next post Sofinnova Investments Inc. Purchases 323,303 Shares of Kura Oncology, Inc. (NASDAQ:KURA)